A Single-volunteer Study of Immune Response Following OTS-412 Vaccinia Virus Systemic Injection(Self-experiment)

Clinical trial NCT07302945 · COMPLETED

Trial details

NCT number: NCT07302945
Sponsor: Bionoxx Inc.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2022-01-04
Primary completion: 2022-01-14
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.